This review summarizes recent developments of various lipid-based liver-targeting technologies, namely solid-lipid nanoparticles, liposomes, niosomes and micelles, and …
Principal Investigator. Shyh-Dar Li, BSc (Pharm), PhD. Angiotech Professor in Drug Delivery. Phone: 604-827-0675. Email: [email protected]. Dr. Shyh-Dar Li received a …
Shyh-Dar Li Hepatitis B virus (HBV) can rapidly replicate in the hepatocytes after transmission, leading to chronic hepatitis, liver cirrhosis and eventually …
Dr. Shyh-Dar Li and Dr. Jiamin Wu Researchers at the University of British Columbia have created a pain-free drug delivery method that could make managing …
Researchers at the Li Lab have developed oral insulin drops that when placed under the tongue are quickly and efficiently absorbed by the body, potentially replacing …
Contribute to hongyib/fr development by creating an account on GitHub.
Three liposomal formulations were compared for delivery of ACP to a multidrug resistant tumor. Methods: Three different liposomes (DMPC, DPPC and DSPC as the main lipid …
In this study, we developed a click chemistry platform to conjugate mPEG of three different M.W. (low: 550 Da; medium: 2000 Da; high: 5000 Da) to a small molecular anti-tumor …
Dr. Shyh-Dar Li, BSc (Pharm), PhD. Angiotech Professor in Drug Delivery. Profile. Dr. Shyh-Dar Li received a BSc in Pharmacy from National Taiwan University and a PhD in …
Postdoctoral Fellow (PDF) Position in Targeted Drug Delivery and Nanomedicine. One full-time postdoctoral position is available in the lab of Dr. Shyh-Dar Li at the Faculty of …